Monday 29 May 2017 - Wednesday 31 May 2017
Location Weggis, Switzerland
After last year's successful kick-off meeting, the EpiGeneSwiss meeting will take place again in Weggis, Switzerland.
This year we have added one day in addition to accommodate more topics and more talks that will be chosen from the abstracts, and to enhance interactions and networking.
The meeting is open to EpiGeneSwiss members and non-member labs.
- RNA and Transcription
- Chromatin Dynamics
- Chromatin Organisation
- Nuclear Architecture
- Chromatin and DNA Repair
Keynote speakers :
- Maria Elena Torres-Padilla (Helmholtz Center Munich, Germany)
- Denis Duboule (EPFL and University of Geneva, Switzerland)
We are looking forward to seeing you in Weggis.
Monday 19 June 2017 - Wednesday 21 June 2017
The focus of the 2017 IMB Conference is on “Gene Regulation by the Numbers: Quantitative Approaches to Study Transcription”.
The conference will explore the latest findings and technological developments in the field of gene regulation. The regulation of gene expression is a highly complex process in which numerous different factors play a role, such as signalling pathways, transcription factors and epigenetic modifications. With the recent surge in the development of omics technologies, researchers have generated vast amounts of data describing the contribution of these factors to controlling gene activity. However, interpreting, validating and integrating the data remains a major challenge. A combination of quantitative analysis and experimental research is therefore crucial to draw a complete picture of gene regulation.
Tuesday 11 July 2017 - Thursday 13 July 2017
Location Bristol, United Kingdom
The MRC Integrative Epidemiology Unit at the University of Bristol invites all professionals interested in aetiological epidemiology and Mendelian randomization to attend our conference on the subject from 11th to 13th July 2017 in Bristol, UK.
Call for abstracts - deadline 2 May 2017
We welcome contributions in any area of the development, use and translation of Mendelian randomization, including:
- methodological developments
- applications in any area of health
- social science, metabolomics, target development, data mining, genome-wide approaches.
Abstract submission is now open, and details on how to submit can be found on the conference website (link below)
Registration now open
For more information about the conference and details on how to register, please visit the conference website.
Updates on confirmed speakers and the programme will be posted on the website.
Please circulate this call to other interested colleagues.
We look forward to welcoming you to Bristol in 2017.
Wednesday 30 August 2017 - Friday 01 September 2017
Location EMBL ATC, Heidelberg, Germany
The nucleosome is the fundamental building block of chromatin organisation and genome function. The 20th anniversary of the high resolution nucleosome structure marks a milestone for bringing together leading researchers to update progress and identify opportunities for an integrated understanding of the role of the nucleosome in chromatin function.
The aim of this conference is to integrate and extend understanding of the links between nucleosome structural properties and the functional roles of chromatin. This will enable new insights into the relationship between atomic details and genome-wide behaviour at the heart of the highly conserved histone-based packaging of eukaryotic genomes.
Wednesday 06 September 2017 - Friday 08 September 2017
Location Planegg-Martinsried, Germany
This EMBO Workshop features histone variants, which are part of an interconnected "epigenetic" network including DNA methylation, posttranslational histone modifications, chromatin remodeling, regulatory RNAs and nuclear organization. Worldwide research on histone variants over the last years has revealed their important function in gene regulation, cell cycle progression, DNA damage repair, genome stability, cell differentiation and organism development. Additionally, recent studies have highlighted the role of mutations or deregulation of expression of histone variants and their binding partners in diverse diseases, most notably cancer.
Thursday 07 September 2017 - Sunday 10 September 2017
Location Alicante, Spain
The nervous system contains several hundred neuronal subtypes and glial cells with specific gene expression pattern defining each of these cell types. Indeed, a large number of neurological diseases are the consequence of an inappropriate cell fate commitment. Therefore, it is crucial to understand the regulatory mechanisms involved in the establishment of specific transcriptional programs defining distinct cell types during nervous system development. Though this field is rapidly expanding and the implications of this knowledge for development and disease are enormous.
The cell fate commitment in the nervous system relies on the timely establishment of cell type specific transcriptional program. Furthermore, misregulation in the gene regulatory circuitry underlying nervous system development has been observed in many neurological diseases. A number of transcription factors and ‘epigenetic’ modifications are increasingly being implicated in defining these gene expression programs and therefore cellular diversity during nervous system development.
We aim to organize this EMBO Conference to comprehensively discuss these players and mechanisms which will cover the following topics in the context of their function in neural fate specification:
- Histone modifications
- Modifications of DNA
- Noncoding genome
- Chromatin remodeling
- Function of distal regulatory elements
- Nuclear organization
- Single cell transcriptome and epigenome
- Systems biology
- Novel mechanisms, molecular tools and approaches
This EMBO Conference will provide participants with an introduction to the key discoveries and fundamental concepts in gene regulatory mechanisms in neural fate decisions, access to the latest results, ideas and open questions as well as an outlook into the future of this field. The conference will also promote young scientists to interact with pioneers in the field and learn about the latest developments from those driving them. The interdisciplinary nature of the conference would further facilitate establishment of new connections and collaborations between labs.
Thursday 12 October 2017 - Friday 13 October 2017
Location London, UK
After our two successful editions, we are glad to announce the 3rd Annual Epigenetics Discovery Congress, which will be taking place on the 12th - 13th of October 2017 in London, UK.
With a tremendous progress in technology to generate and analyze reference epigenomes, the epigenetics field is fetching a lot of importance and attention across all medical science’s areas. Additionally, novel epigenetic molecules across many target classes for drug discovery, have been the prime focus of the pharmaceutical industry.
To meet and support this pace of the epigenetics research and development field, the 3rd Annual Epigenetics Discovery Congress will present novel research and address challenges right from the molecular sciences & disease diagnosis to drug discovery streams. The congress will also be a great platform to learn about novel technologies like next generation sequencing and single cell analysis.
Wednesday 25 October 2017
Location CosmoCaixa Science Museum, Barcelona, Spain
The 'Epigenetic mechanisms in health and disease' debate, co-organized by B·Debate (an initiative of Biocat and "la Caixa" Foundation), the Molecular Biology Institute of Barcelona (IBMB-CSIC) and Josep Carreras Leukemia Research Institute (IJC), will review the progress made in epigenetics as a new multi-disciplinary field with an enormous scientific and therapeutic potential for cancer, cardiovascular diseases, aging, neurodegenerative diseases and diabetes.
This debate is the last of a series of Barcelona Conferences on Epigenetics and Cancer (BCEC), know more about this serie and previous editions here.
Registration is now open and comes at 80 Euros only.
- Carl Wu (Johns Hopkins University School of Medicine, USA)
- Marian Martínez-Balbas (IBMB-CSIC, Barcelona)
- Susan Gasser (Friedrich Miescher Institute, Switzerland)
- Ferran Azorin (IBMB-CSIC, Barcelona)
- Genevieve Almouzni (Institut Curie / CNRS, France)
- Wendy Bickmore (University of Edinburg, UK)
- Ari Melnick (Weill Cormel Medical College, USA)
- Sylvia Erhardt (University of Heidelberg, Germany)
- Amos Tanay (The Weizmann Institute, Israel)
- Henk Stunnenberg (Radboud University Medical Centre, NL)
- Manel Esteller (PEBC-IDIBELL, Barcelona)
- Florian Heidel (Jena University Hospital, Germany)
Participants will further have access to the 2nd PMPPC symposium celebrated on the afternoon of October 26. Confirmed speakers include:
- Victor Corces (Emory University, USA)
- Carlo M. Croce (Ohio State University, USA)
- Jose-Luis Gómez-Skarmeta (CABD, Sevilla)
- Alain Balmain (UCSF, USA)
Sunday 12 November 2017 - Tuesday 14 November 2017
Location Heidelberg, Germany
The current speed at which novel high-throughput technologies are developed and large-scale biological data are produced offers tremendous opportunities for enhancing our molecular understanding of biological systems. One of the biggest challenges will be to interpret these large-scale biological “omics” data and to develop computational and statistical approaches to generate a coherent biological model that will enable us to address novel questions about the consequences of genetic and environmental perturbations in complex biological systems.
This conference will provide a platform for bringing together leading researchers from computational biology and various “omics” fields (e.g. genomics, genetics, proteomics, metabolomics, lipidomics, etc) to present their latest work and discuss applications, future ideas and challenges for integrating large-scale biological data across different biological technologies and disciplines.
This conference aims to bring together experts from various ‘omics fields and computational biology to discuss applications and inspire new ideas for integrating and interpreting data across the different omics technologies. We believe it will provide a interdisciplinary platform for discussing future collaborations between the different omics fields.
Recent advances in genomics, proteomics, and metabolomics
Integrating different ‘omics data
Post-translational modification: expanding proteome diversity
Novel ‘omics technologies - including ‘omics and structural biology
Clinical applications of multi-omics